Quick Takeaways
- Christopher M. Smith has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $18,262,882.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Christopher M. Smith and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | Chief Executive Officer | $15,690,205 | 23 Feb 2025 | ||
| QDEL | QuidelOrtho Corp | Director | $2,462,640 | 06 Jun 2023 | ||
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director | $110,037 | 04 Jun 2025 | ||
| AKUS | Akouos, Inc. | Director | 23 Jun 2022 | |||
| OCDX | Ortho Clinical Diagnostics Holdings plc | Chairman and CEO, Director | 27 May 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|